Comment on "Evaluation of serum fatty acid binding protein-4 (FABP-4) as a novel biomarker to predict biopsy outcomes in prostate biopsy naïve patients"

Int Urol Nephrol. 2020 Oct;52(10):1907-1908. doi: 10.1007/s11255-020-02479-x. Epub 2020 May 6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers
  • Biopsy
  • Fatty Acid-Binding Proteins*
  • Humans
  • Male
  • Prostate*

Substances

  • Biomarkers
  • Fatty Acid-Binding Proteins